The startup develops a non-invasive medical device that utilizes magnetic fields to deliver DNA, RNA, and other charged molecules directly into cells. This technology facilitates advancements in cell therapies, cancer drug delivery, and DNA vaccines, enabling researchers to create effective treatments for various diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods of delivering therapeutic molecules into cells often involve invasive procedures or lack precise targeting, limiting their effectiveness and potential applications. Traditional delivery systems may also damage cells or trigger unwanted immune responses, hindering the development of safe and efficient treatments.
Solution
This startup is developing a non-invasive medical device that uses magnetic fields to enhance the delivery of DNA, RNA, and other charged molecules directly into cells. By applying precisely controlled magnetic fields, the device aims to improve cellular uptake of therapeutics, reduce off-target effects, and minimize cellular damage. This technology has the potential to improve cell therapies by enhancing transfection efficiency, enable more effective cancer drug delivery by targeting tumor cells, and facilitate the development of DNA vaccines by improving antigen presentation.
Target Audience
The primary target audience includes researchers and clinicians in the fields of cell therapy, oncology, and vaccine development, as well as pharmaceutical companies seeking to improve drug delivery methods.
Features
- Non-invasive delivery of therapeutic molecules using magnetic fields
- Enhanced cellular uptake of DNA, RNA, and other charged molecules
- Precise targeting to specific cells or tissues
- Reduced off-target effects and cellular damage
- Compatibility with various therapeutic modalities, including cell therapies, cancer drugs, and DNA vaccines